KRISTEN SHIRES: Open Payments
NPI 1730885765 · NORWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,576 in 62 payments from 26 companies in 2025. Trend: 2023 $1,146 · 2024 $1,691 · 2025 $1,576
Food & beverage: $1,576
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 1 | $166 |
| AstraZeneca Pharmaceuticals LP | 2 | $146 |
| Astellas Pharma US Inc | 4 | $105 |
| Novartis Pharmaceuticals Corporation | 5 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $90 |
| Amgen Inc. | 4 | $86 |
| Lilly USA, LLC | 3 | $82 |
| E.R. Squibb & Sons, L.L.C. | 4 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $76 |
| Novo Nordisk Inc | 4 | $76 |
Products named: XYOSTED, AIRSUPRA, Veozah, LEQVIO, TRINTELLIX, ELIQUIS, TRELEGY ELLIPTA, JARDIANCE.
Industry payments across CT — which companies pay providers there.
